Eloralintide (10mg)

Description

Eloralintide (LY3841136) is an investigational, once-weekly peptide medication being developed by Eli Lilly for the treatment of obesity and overweight. It is not currently approved for general clinical use by major regulators and remains in clinical development.

Unlike GLP-1 medications such as semaglutide, eloralintide is a selective amylin receptor agonist. Amylin is a naturally occurring hormone released alongside insulin after meals. It helps regulate appetite, slows stomach emptying, and contributes to feelings of fullness.

How does it work?

Researchers believe eloralintide works by:

• 🍽️ Increasing feelings of fullness (satiety)
• 📉 Reducing appetite and food intake
• 🕒 Slowing gastric emptying
• ⚖️ Supporting body weight reduction
• 🩸 Helping regulate post-meal glucose metabolism through amylin signaling

Unlike non-selective amylin agonists, eloralintide was designed to target specific amylin receptors, with the aim of maintaining effectiveness while potentially improving tolerability.

Potential Benefits Being Studied

Clinical trials are investigating whether eloralintide may:

• ✔️ Promote significant weight loss.
• ✔️ Reduce appetite and food cravings.
• ✔️ Improve feelings of fullness after meals.
• ✔️ Improve waist circumference and other metabolic measures.
• ✔️ Complement existing obesity therapies, including combination treatment with tirzepatide.

Clinical Trial Results

Early clinical studies have shown promising results:

• Phase 1 studies found reduced appetite and body weight with once-weekly dosing while supporting a favorable pharmacokinetic profile.
• In a 48-week Phase 2 trial, higher-dose groups achieved substantial average weight loss, along with improvements in several metabolic markers, although gastrointestinal side effects and fatigue were reported more commonly at higher doses.

Common Side Effects Reported in Trials

The most commonly reported adverse effects include:

• Nausea
• Decreased appetite
• Fatigue
• Headache
• Gastrointestinal symptoms such as constipation or abdominal discomfort